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Summary
Little is known about how diet and energy metabolism
interact in determination of lifespan under ad libitum
feeding. From 12 weeks of age until death, male and
female wild-type (WT) and transgenic (TG) mice with
increased skeletal muscle mitochondrial uncoupling
(HSA-mUCP1 mice) were fed one of three different semi-
synthetic diets differing in macronutrient ratio: control
(high-carbohydrate⁄low-fat-HCLF) and two high-fat diets:
high-carbohydrate⁄high-fat (HCHF), and low-carbohy-
drate⁄high-fat (LCHF). Compared to control and LCHF,
HCHF feeding rapidly and signiﬁcantly increased body fat
content in WT. Median lifespan of WT was decreased by
33% (HCHF) and 7% (LCHF) compared to HCLF. HCHF sig-
niﬁcantly increased insulin resistance (HOMA) of WT from
24 weeks on compared to control. TG mice had lower lean
body mass and increased energy expenditure, insulin sen-
sitivity, and maximum lifespan (+10%) compared to WT.
They showed a delayed development of obesity on HCHF
but reached similar maximum adiposity as WT. TG median
lifespan was only slightly reduced by HCHF ()7%) and
unaffected by LCHF compared to control. Correlation
analyses showed that decreased longevity was more
strongly linked to a high rate of fat gain than to adiposity
itself. Furthermore, insulin resistance was negatively and
weight-speciﬁc energy expenditure was positively corre-
lated with longevity. We conclude that (i) dietary macro-
nutrient ratios strongly affected obesity development,
glucose homeostasis, and longevity, (ii) that skeletal mus-
cle mitochondrial uncoupling alleviated the detrimental
effects of high-fat diets, and (iii) that early imbalances in
energy homeostasis leading to increased insulin resis-
tance are predictive for a decreased lifespan.
Key words: aging; body composition; energy expendi-
ture; glucose tolerance test; high-fat diet; life expectancy;
macronutrients; mouse; physical activity.
Introduction
Obesity rates are increasing dramatically worldwide, which con-
stitutes a serious strain on health care systems because of the
obesity-associated health problems such as cardiovascular dis-
ease or diabetes (Withrow & Alter, 2010). It is generally
accepted that obesity leads to a reduced life expectancy because
of these associated health problems. The most important dietary
factor contributing to the development of obesity is a high calo-
ric intake, which is linked to a high dietary energy density (Rolls,
2009). Energy density of fat is twice as high as that of protein
and carbohydrates, and dietary fat content has long been con-
sidered the most important factor contributing to increasing
obesity prevalence (Bray et al., 2004). High-fat diets are known
to induce obesity in many animal models and have also been
shown to reduce lifespan (Otabe et al., 2007). However, the
respective roles of dietary carbohydrate and protein in develop-
ment or prevention of obesity are currently discussed quite
intensively. We have shown previously in a mouse model that
increasing the protein:carbohydrate ratio in a high-fat diet
delayed development of obesity and improved glucose homeo-
stasis (Klaus, 2005). A recent meta-analysis of controlled human
trials showed that low-carbohydrate⁄high-protein diets are
more effective at short term than low-fat diets in reducing
weight and cardiovascular disease in humans (Hession et al.,
2009). It has therefore been suggested that increasing the die-
tary protein to carbohydrate ratio could be effective in improv-
ing weight and metabolic control in humans (Hession et al.,
2009; Acheson, 2010). However, there are still not sufﬁcient
data on long-term health effects of such diets.
Regarding dietary effects on lifespan, dietary (DR) or caloric
restriction (CR) has been the main research focus for several dec-
ades. Many effects of DR are thought to be linked to changes in
macronutrient balance, but the effects of macronutrient balance
on lifespan were almost exclusively investigated in insects so far
(Simpson & Raubenheimer, 2009). In Drosophila it was shown
that the addition of essential amino acids to a lifespan increasing
DR regime reduced lifespan to the level of fully fed ﬂies, suggest-
ing an imbalance of dietary amino acid ratios to be a key factor
in regulation of lifespan (Grandison et al., 2009). DR is generally
considered to increase lifespan in species ranging from yeast
over ﬂies and mice to monkeys (Fontana et al., 2010), but
recently two independent studies showed that effects of DR on
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ldifferent recombinant inbred mice strains range from life
extension to life shortening (Liao et al., 2010; Rikke et al.,
2010). On the other hand, very little is known about how dietary
macronutrient composition affects lifespan when fed ad libitum,
which is probably more relevant to the human situation. Particu-
larly, there is a scarcity of studies examining the role of dietary
macronutrient ratios on aging and longevity in mammals. One
study performed in two different strains of wistar rats did not
ﬁnd conclusive evidence for an inﬂuence of different dietary
macronutrient contents on longevity (Preuss, 1997). Another
study performed in genetically obese and nonobese mice
reported a high-fat diet–induced decrease in lifespan in geneti-
cally obese mice only (Smith et al., 1991).
It has lately emerged that aging is not a random process but
determined by a genetically regulated longevity network which
can be modulated genetically and also by environmental fac-
tors (Ladiges et al., 2009; Blagosklonny et al., 2010; Chen
et al., 2010). But so far, little is known about the interaction of
diet composition and genetic and metabolic factors with regard
to aging and lifespan. Therefore, here we aimed to dissect the
role of macronutrients on obesity, aging and lifespan and their
interaction with energy and glucose homeostasis to explore
their respective role in aging and longevity. To this means, we
investigated the effects of lifelong feeding of three different,
semisynthetic diets with identical macronutrient sources but
different macronutrient ratios, two of which had an identical
high-fat content but different protein:carbohydrate ratios.
These diets were fed to wild-type mice (WT) and transgenic
mice (TG) with skeletal muscle mitochondrial uncoupling
induced by ectopic expression of the uncoupling protein 1 in
skeletal muscle (HSA-UCP1 mice) (Klaus et al., 2005). UCP1
expression is normally restricted to brown fat mitochondria
where it is responsible for cold-induced nonshivering thermo-
genesis (Klaus et al., 1991). We found that UCP1 displayed
native behavior in isolated skeletal muscle mitochondria from
TG mice. Mitochondria showed an increased uncoupling that
was activated by fatty acids and could be inhibited by purine
nucleotides (Keipert et al., 2010). On the other hand, UCP1
expression in brown fat was not affected by the transgene (Kei-
pert, unpublished results). HSA-UCP1 mice display decreased
body weight (lean mass and fat mass), increased energy expen-
diture, and increased metabolic ﬂexibility (i.e. a faster switch
between carbohydrate und lipid oxidation), as well as lower
insulin levels and increased insulin sensitivity (Klaus et al.,
2005; Katterle et al., 2008; Neschen et al., 2008). Also, using a
different transgenic mouse model of UCP1 expression in skele-
tal muscle, a slightly prolonged median lifespan of about 10%
has been shown in transgenic mice on a standard chow diet
(Gates et al., 2007). However, we have shown that HSA-UCP1
mice are not in general resistant to diet-induced obesity but
rather show a delayed development of obesity and a dissocia-
tion of obesity and insulin sensitivity when fed a high-carbohy-
drate⁄high-fat diet (Katterle et al., 2008). Therefore, we
wanted to investigate whether the increased insulin sensitivity
of TG mice could be able to counteract deleterious effects of
high-fat diets even in the presence of obesity. Inclusion of this
transgenic mouse model can also help to identify individual
predictive markers for lifespan by broadening the range of phe-
notypic variability regarding energy and glucose homeostasis.
The aim of our study was thus to examine the role of dietary
macronutrient ratios on lifespan and on energy metabolism,
obesity development, and glucose homeostasis throughout life.
Furthermore, we aimed to investigate whether alterations in
skeletal muscle energy metabolism that lead to increased insu-
lin sensitivity are able to counteract possible deleterious dietary
effects on longevity and survival. Finally, we tried to identify
early factors of energy metabolism and⁄or glucose homeosta-
sis, which could represent metabolic biomarkers predictive for
lifespan and survival.
Results
Lifespan
Analyses of survival curves (Mantel-Cox, log-rank test) as well
as mean lifespan (Mann–Whitney test) did not show signiﬁcant
gender differences in either WT or TG mice. Also, maximum
lifespan (deﬁned as oldest surviving 10% of all mice) was not
different between males and females (males 1041 ± 28 days,
females 1065 ± 7 days). Therefore, survival data were ana-
lyzed for both sexes combined (Fig. S1 and Table S1 for
survival characteristics of male and females analyzed sepa-
rately). There was a signiﬁcant diet effect on survival of WT
mice with mice on the control (HCLF) diet showing the longest
survival (Fig. 1A) and the highest mean lifespan (Table 1).
Compared to the control diet, mean lifespan was reduced on
the two high-fat diets ()17% on the (LCHF diet and )33% on
the HCHF diet). Log-rank (Mantel-Cox) test showed signiﬁcant
differences in survival between all three diets in WT (HCLF vs.
HCHF P < 0.0001; HCLF vs. LCHF P = 0.004; HCHF vs. LCHF
P = 0.003).
In TG mice survival was much less affected by the diets than in
WT (Fig 1B). The only signiﬁcant difference in survival was obvi-
ous between the control (HCLF) diet and the HCHF diet
(P < 0.003, Mantel-Cox test). Mean lifespan of TG on the HCHF
diet was reduced by 13% compared to the control (HCLF) diet
(Table 1).
Overall, in TG mice maximum lifespan (deﬁned as the oldest
surviving 10% of all mice of one genotype) was increased by
about 100 days compared to WT (WT 992 ± 20 days, TG
1094 ± 22 days, P = 0.002). Minimum lifespan was increased
as well by over 20% (youngest 10% surviving mice in WT
335 ± 12 days, in TG 411 ± 27 days, P < 0.05), indicating an
overall shift in early mortality. Comparison of TG with WT mice
on the different diets showed signiﬁcantly different survival
curves of TG on the two high-fat diets (HCHF, P < 0.0001;
LCHF, P < 0.01, Mantel-Cox test) compared to WT, but not on
the HCLF control diet (Fig. 1C–E). Mean lifespan of WT and TG
was similar on the control (HCLF) diet but not on the two high-
fat diets. Compared to WT, mean lifespan of TG mice on the
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123high-fat diets was signiﬁcantly increased by 22% (LCHF) and
34% (HCHF) (Table 1).
Body composition
Body weight and body composition throughout life are pre-
sented in Fig. 2. Starting body weight of TG was lower than
that of WT, mainly attributed not only to decreased lean
body mass (LBM) but also to a slightly lower body fat con-
tent (Fig. 2, Table 2). At this time (week 12), relative body
fat content of TG mice was slightly decreased in males and
slightly increased in females compared to WT (data not
shown). Feeding of the HCHF diet increased body weight
and body fat signiﬁcantly from week 16 on compared to the
control diet (HCLF) in both male and female WT mice. In
contrast, compared to the control (HCLF) diet, the LCHF diet
led to only minimal increases in body weight and body fat
in male mice (Fig. 2A,B) and even slightly decreased body
weight and body fat in female mice after 70 weeks of age
(Fig. 2D,E).
Lean body mass (LBM) was always lower in TG mice than in
WT. In both, it showed only minor increases until about
30 weeks of age and stayed rather stable thereafter. Diet com-
position did not affect LBM at all in female WT and TG (Fig. 2F).
(A) (B)
(E) (D) (C)
Fig. 1 Kaplan–Meier survival curves of wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic macronutrient diets ad libitum from
12 weeks of age (both sexes combined). A signiﬁcant reduction in lifespan of WT high-carbohydrate ⁄ high-fat (HCHF) fed mice compared to high-
carbohydrate⁄ low-fat (HCLF) fed mice was observed (A) (P < 0.0001, log-rank test). Lifespan of low-carbohydrate⁄ high-fat (LCHF) fed WT mice was signiﬁcantly
different from both other diets. In TG animals (B) the only signiﬁcant difference in survival was obvious between the control (HCLF) diet and the HCHF diet
(P < 0.003, log-rank test). (C–E) Lifespan of TG mice in direct comparison to WT mice on each of the three different diets. There was no signiﬁcant difference in
survival between TG and WT on the control HCLF diet (C), but a signiﬁcantly increased median lifespan of TG on the HCHF diet (+42%) (D) and on the LCHF diet
(+13%) (E). n = 37–50.
Table 1 Survival characteristics (days) of wild-type (WT) and transgenic (HSA-UCP1) mice fed three different semisynthetic macronutrient diets (both sexes
combined)
Diet Median Mean Range Oldest 10% Youngest 10% n
WT HCLF 814 807 ± 27 423–1167 1066 ± 40 510 ± 49 37
LCHF 754 668 ± 33 263–976 933 ± 16 295 ± 12 41
HCHF 548 555 ± 23 273–965 828 ± 65 330 ± 21 42
HSA-UCP1 HCLF 849 857 ± 26 421–1192 1132 ± 29 536 ± 46 42
LCHF 852 815 ± 27 315–1303 1103 ± 52 420 ± 33 50
HCHF 785.5 742 ± 31 227–1059 985 ± 27 302 ± 26 40
Oldest (youngest) 10% represents the mean lifespan of the oldest (youngest) surviving 10% of mice from their respective group. Data are reported ± SEM
where appropriate.
HCHF, high-carbohydrate ⁄high-fat; HCLF, high-carbohydrate ⁄ low-fat; LCHF, low-carbohydrate ⁄high-fat.
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124Only male WT mice showed an increase in LBM on the HCHF
diet compared to the other two diets from about week 30 on
(Fig. 2C).
Interestingly, in HCHF fed mice, body fat reached a plateau in
WT male mice at about 20 weeks but was further increased with
age in female WT mice which reached plateau after about
50 weeks of age. The time point at which mice reached their
maximum body weight and body fat levels was highly inﬂuenced
by genotype and diet in both male and female mice (Table 2).
Because of the apparent differences in maximum body fat and
the velocity of body fat gain, we also calculated maximum body
fat levels and the rate of fat gain from dietary intervention start
(week 12) until maximum body fat was reached (Fig. 3). Maxi-
mum relative body fat levels were not different between the
control (HCLF) diet and LCHF diet in either sex or genotype
(Fig. 3A,B), which shows that increasing the protein content in a
high-fat diet regime completely prevented the development of
high-fat-induced obesity. On the other hand, feeding of the
HCHF diet resulted in increased maximum body fat levels com-
pared to the other two diets in WT and TG males and females
(Fig. 3A,B). Interestingly, male TG mice reached similar maxi-
mum body fat levels as WT (Fig. 3A), conﬁrming our previous
ﬁndings that TG mice are not generally protected against the
development of obesity (Katterle et al., 2008). The rates of body
weight and body fat gain were highly correlated (R = 0.96).
Body fat variability thus explained over 90% of body weight vari-
ability, which clearly shows that it is the most important contrib-
utor to body weight changes in adult mice. The rate of body fat
gain was lowest in male and female TG mice on the control
(HCLF) diet and highest in female WT mice on the HCHF diet,
followed by males on the HCHF diet (Fig. 3D,E). Overall, TG mice
showed much lower velocity of body fat accretion than WT
mice.
Energy expenditure and physical activity
Energy expenditure was measured by indirect calorimetry con-
tinuously over 24 h in a subset of mice in week 31. Total energy
expenditure was higher in WT mice than in TG mice (Fig. 4A,B)
because of the higher body weight of WT. The increased body
weight also resulted in an increased total daily energy expendi-
ture (TEE) of both male and female WT mice on the HCHF diet
compared to the other two diets. TEE was determined by body
weight to almost 80% (r = 0.885). When corrected for body
weight, weight-speciﬁc TEE was signiﬁcantly affected by geno-
type and diet in both males and females and increased in TG
compared to WT (Fig 4C,D) as reported previously (Klaus et al.,
2005; Katterle et al., 2008). However, post hoc tests only
(A) (B)
(f) (E) (D)
(C)
Fig. 2 Body weight and body composition development of wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic macronutrient
diets ad libitum from 12 weeks of age. Body weight (A, D), body fat content (B, E), and lean body mass (C, F) of male (A–C) and female (D–F) mice. Data are
plotted until the week of 50% survival (initial n = 17–27). Body weight and body fat was signiﬁcantly increased in WT high-carbohydrate ⁄high-fat (HCHF)
compared to high-carbohydrate ⁄low-fat (HCLF) mice from week 16 on, in TG HCHF compared to HCLF mice from week 36 on.
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125Table 2 Phenotypic data of male and female wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic macronutrient diets ad
libitum from 12 weeks of age (data are shown as mean ± SEM)
WT HSA-UCP1 (TG) ANOVA
HCLF HCHF LCHF HCLF HCHF LCHF Diet Genotype
Males
Before dietary switch
Body weight week 12 (g) 27.1 ± 0.7 28.8 ± 0.8 28.9 ± 0.6 19.4 ± 0.6 19.1 ± 0.4 19.3 ± 0.5 ns <0.0001
Body fat mass week 12 (g) 3.0 ± 0.2
a 4.1 ± 1
b 4.2 ± 0.4
b 2.2 ± 0.1 2.3 ± 0.1 2.3 ± 0.1 <0.05 <0.0001
Lean body mass week 12 (g) 24.1 ± 0.6 24.3 ± 0.6 24.7 ± 0.4 17.1 ± 0.6 16.8 ± 0.4 17.0 ± 0.4 ns <0.0001
After dietary switch
Body weight week 24 (g) 36.2 ± 1.1
a 45.4 ± 0.9
b 41.7 ± 1.3
ab 22.6 ± 0.6 24.3 ± 0.8 23.9 ± 0.7 <0.0001 <0.0001
Body fat mass week 24 (g) 10.8 ± 0.7
a 18.2 ± 0.7
b 14.2 ± 1.1
c 3.5 ± 0.2 5.0 ± 0.4 4.2 ± 0.3 <0.0001 <0.0001
Time of max BF (week) 53 ± 4 53 ± 3 48 ± 2 75 ± 6
a 72 ± 4
ab 60 ± 4
b <0.05 <0.0001
Max body fat (g) 16.9 ± 0.9
a 23.0 ± 0.9
b 18.9 ± 1.1
a 8.4 ± 0.8
a 18.8 ± 1.5
b 9.4 ± 0.8
a <0.0001 <0.0001
Physical activity week 31
(counts ⁄ day ⁄1000)
410 ± 35 352 ± 53 327 ± 40 435 ± 57 452 ± 53 493 ± 46 ns <0.05
Females
Before dietary switch
Body weight week 12 (g) 22.0 ± 0.3 22.3 ± 0.7 20.7 ± 0.4 15.8 ± 0.4 16.1 ± 0.3 14.9 ± 0.3 <0.01 <0.0001
Lean body mass week 12 (g) 19.1 ± 0.3 19.1 ± 0.4 18.3 ± 0.3 13.6 ± 0.3 13.4 ± 0.2 12.8 ± 0.3 <0.05 <0.0001
Body fat mass week 12 (g) 2.8 ± 0.2 3.0 ± 0,4 2.4 ± 0.1 2.2 ± 0.1 2.4 ± 0.2 2.1 ± 0.1 ns <0.01
After dietary switch
Body weight week 24 (g) 28.1 ± 0.8
a 39.7 ± 1.6
b 28.1 ± 0.9
a 17.9 ± 0.5 18.7 ± 0.6 17.4 ± 0.3 <0.0001 <0.0001
Body fat mass week 24 (g) 7.6 ± 1.0
a 18.4 ± 1.8
b 7.5 ± 0.8
a 3.0 ± 0.2 4.0 ± 0.5 2.9 ± 0.2 <0.0001 <0.0001
Time of max BF (week) 81 ± 5
a 59 ± 3
b 56 ± 4
b 95 ± 5
a 76 ± 6
b 86 ± 5
ab <0.0001 <0.0001
Max body fat (g) 20.5 ± 1.4
a 31.3 ± 1.6
b 17.5 ± 1.9
a 8.2 ± 0.8
a 15.5 ± 2.6
b 7.2 ± 0.6
a <0.0001 <0.0001
Physical activity week 31
(counts ⁄ day ⁄1000)
685 ± 106 555 ± 69 765 ± 75 479 ± 57 578 ± 112 767 ± 67 <0.05 ns
Different superscript letters denote signiﬁcant differences between the diet groups within one genotype (ANOVA).
HCLF, high-carbohydrate ⁄low-fat; HCHF, high-carbohydrate ⁄high-fat; LCHF, low-carbohydrate ⁄high-fat.
(A) (B)
(D) (C)
Fig. 3 Maximum body fat content and rate of body fat gain of wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic
macronutrient diets ad libitum from 12 weeks of age. Maximum relative body fat levels (A, B) and rate of fat gain from week 12 until maximum body fat levels
were reached (C, D) of male (A, C) and female (B, D) mice. Different superscript letters denote signiﬁcant differences between the diet groups within one genotype
(ANOVA, n = 17–26).
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126showed signiﬁcant differences in weight-speciﬁc TEE of female
WT on the HCHF diet compared to the other two diets (Fig. 4D).
Together this suggests that diet composition by itself had only
minor, if any effects on energy expenditure. Similar results were
seen when resting energy expenditure was calculated (data not
shown).
Spontaneous physical activity was measured over a period of
3 days after the measurement of energy expenditure by using
infrared movement sensors. As shown in Table 2, in male mice
there was a small genotype effect with TG mice showing slightly
higher activity levels than WT with no signiﬁcant inﬂuence of
diet. Female mice on the other hand showed overall higher
activity levels than males and minor diet effects with a tendency
for increased activity levels on the LCHF diet.
Glucose homeostasis and insulin resistance
Nonfasted (postprandial) blood glucose and insulin levels were
measuredin asubsetofmiceinregularintervalsfromweek12to
60 oflife aspresented in Fig. 5. Regardless ofthe diet,mice were
able to retain normo-glycemia throughout this period, which is
in general assumed at 60–130 mg dL
)1 in mice. However,
repeated measures analysis showed a signiﬁcant time effect on
blood glucose in male and female mice. In WT mice, there was a
tendencyforatransientincreaseinbloodglucoseatweek24(i.e.
12 weeks after diet start) on HCHF compared to the other diets
and a normalization thereafter (Fig. 5A,B). Blood glucose levels
at week 24 were signiﬁcantly affected by genotype (P < 0.0001
in both males and females) and also by diet (P < 0.05 in males
and < 0.001 in females, Table 3). Female WT mice on HCHF also
displayed increased blood glucose in week 24 compared to the
other two diets. Before diet start and after week 24, there were
no signiﬁcant genotype effects on blood glucose levels (Table 3).
Female TG mice showed rather stable glucose levels until week
60 of the diet (Fig. 5B). Male TG showed a gradual increase in
blood glucose on the HCHF diet until week 60 (Fig. 5A, Table 3).
Calculation of the area under the curve (AUC) of glucose devel-
opment during aging showed a signiﬁcant genotype effect
(P = 0.002males, P = 0.003 females)butasigniﬁcant dieteffect
only in males (P = 0.025, two-way ANOVA; Table S2). More pro-
nounced effects of diet and genotype were apparent on the
development of insulin levels during aging. Repeated measures
analysisshowedahighlysigniﬁcanttimeeffectoninsulinlevelsin
both male and female (P < 0.0001). Insulin increased with age
especially in male WT mice, which showed progressively
increased insulin levels until about 48 weeks of age with only
minor diet effects (Fig. 5C). Female WT mice showed also a
similar increase in insulin on the HCHF diet but much lower levels
on the other two diets (Fig. 5D, Table 3). AUC for insulin
during aging showed highly signiﬁcant effects of genotype
(P < 0.0001 for both males and females) and diet (P < 0.0001
males,P < 0.001females,two-way ANOVA,Table S2).
Homeostasis Model Assessment for insulin resistance (HOMA-
IR) was calculated as a correlate for insulin sensitivity according
to Lansang et al., (2001). Similar to insulin data, there were
highly signiﬁcant effects of genotype and diet in both males and
females (Table 3). Already, at week 24 WT mice on the HCHF
diet showed signiﬁcantly increased HOMA-IR compared to the
(A) (B)
(D) (C)
Fig. 4 Total daily energy expenditure (TEE) of wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic macronutrient diets ad
libitum from 12 weeks of age. TEE per animal (A, B) and weight-speciﬁc TEE (C, D) of male (A, C) and female (B, D) mice was measured at 31 weeks of age.
Different superscript letters denote signiﬁcant differences between the diet groups within one genotype (ANOVA, n = 8–13).
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127control (HCLF) but also compared to the LCHF diet, which was
most pronounced in male mice. At week 60, HOMA-IR of WT
mice was not further increased in HCHF, indicating that maxi-
mum levels of insulin resistance had already been reached after
12 weeks of dietary intervention. TG mice showed lower
HOMA-IR values than WT at both time points. However, at week
(A) (B)
(D) (C)
Fig. 5 Development of blood glucose and insulin levels (3 h fasted) in wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic
macronutrient diets ad libitum from 12 weeks of age. (A,B) Blood glucose levels at 24 weeks were signiﬁcantly inﬂuenced by genotype (P < 0.0001) and diet
(P < 0.05) in male (A) and female mice (B) mice (C,D) Plasma insulin was signiﬁcantly inﬂuenced by genotype and diet in male (C) and female mice (D) mice
(2-way ANOVA, n = 8–13).
Table 3 Glucose, Insulin and Homeostasis Model Assessment for insulin resistance (HOMA-IR) at different time points of male and female wild-type (WT) and
transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic macronutrient diets ad libitum from 12 weeks of age (data are shown as mean ± SEM)
WT HSA-UCP1 (TG) ANOVA
HCLF HCHF LCHF HCLF HCHF LCHF Diet Genotype
Males
Before dietary switch
Glucose week 12 (mg dL
)1) 116 ± 4 118 ± 7 112 ± 8 103 ± 6 96 ± 4 91 ± 7 ns <0.001
After dietary switch
Insulin week 24 (lgL
)1) 3.39 ± 0.48
a 10.78 ± 1.00
b 7.51 ± 1.54
b 0.75 ± 0.12 1.40 ± 0.28 0.95 ± 0.13 <0.0001 <0.0001
Insulin week 60 (lgL
)1) 6.14 ± 1.22 9.26 ± 1.08 7.16 ± 1.21 1.59 ± 0.31
a 7.84 ± 1.18
b 2.60 ± 0.60
a <0.0001 <0.0001
Glucose week 24 (mg dL
)1) 124 ± 5 145 ± 9 131 ± 8 103 ± 5
ab 110 ± 6
a 90 ± 4
b <0.05 <0.0001
Glucose week 60 (mg dL
)1) 110 ± 5 115 ± 3 108 ± 8 112 ± 7
ab 136 ± 7
a 99 ± 6
b <0.01 ns
HOMA-IR week 24 24.9 ± 3.6 92.9 ± 9.2 50.1 ± 8.5 4.7 ± 1.0 9.2 ± 2.1 4.8 ± 0.6 <0.0001 <0.0001
HOMA-IR week 60 40.1 ± 8.1 64.0 ± 7.5 46.2 ± 8.7 10.7 ± 2.1 63.4 ± 9.3 15.0 ± 3.3 <0.0001 0.0002
Females
Before dietary switch
Glucose week 12 (mg dL
)1) 102 ± 4 97 ± 6 94 ± 6 96 ± 4 89 ± 5 93 ± 5 ns ns
After dietary switch
Insulin week 24 (lgL
)1) 1.13 ± 0.36
a 7.12 ± 1.73
b 1.50 ± 0.22
a 0.35 ± 0.06
a 0.66 ± 0.11
b 0.40 ± 0.06
ab <0.0001 <0.0001
Insulin week 60 (lgL
)1) 3.34 ± 0.69 8.35 ± 3.41 3.54 ± 0.43 1.24 ± 0.42 2.89 ± 0.95 1.03 ± 0.31 <0.05 <0.01
Glucose week 24 (mg dL
)1) 104 ± 6
a 134 ± 9
b 107 ± 7
a 91 ± 4 103 ± 4 90 ± 3 <0.001 <0.0001
Glucose week 60 (mg dL
)1) 111 ± 8 100 ± 7 114 ± 7 102 ± 6 107 ± 6 101 ± 5 ns ns
HOMA-IR week 24 7.5 ± 2.5 64.4 ± 17.6 9.3 ± 1.1 1.8 ± 0.3 4.1 ± 0.7 2.1 ± 0.3 <0.0001 <0.0001
HOMA-IR week 60 22.3 ± 5.5 58.3 ± 21.8 24.4 ± 3.6 8.5 ± 3.3 18.6 ± 5.6 6.2 ± 2.1 0.021 0.002
Different superscript letters denote signiﬁcant differences between the diet groups within one genotype (ANOVA).
HCLF, high-carbohydrate ⁄low-fat; HCHF, high-carbohydrate ⁄high-fat; LCHF, low-carbohydrate ⁄high-fat.
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12860, insulin resistance was similar in male TG and WT mice fed
the HCHF diet. In female TG mice, the diet effect was less pro-
nounced than in males (Table 3).
At 60 weeks of age, a glucose tolerance test (GTT) was per-
formed (Fig. 6) with measurements of blood glucose until
240 min after glucose injection and determination of plasma
insulin at baseline, 15, and 30 min after glucose injection (Fig 6,
inserts). There was a signiﬁcant effect of genotype (P < 0.01
and P < 0.05 in male and female mice, respectively, two-way
ANOVA) but not of diet on AUC of blood glucose. Insulin AUC of
male mice was signiﬁcantly affected by genotype and diet
(P < 0.0001 for both, two-way ANOVA) with the HCHF group sig-
niﬁcantly increased in comparison with the other two diets in
both WT and TG mice. In female mice, AUC of insulin was signif-
icantly affected by genotype (P < 0.001) and diet (P < 0.01,
two-way ANOVA, Table S2).
Correlations of phenotypic markers with lifespan
To identify the metabolic traits that are predictive for increased
or decreased lifespan, we performed a correlation analysis
between lifespan of individual mice and different phenotypic
markers as shown in Table 4. In TG but not in WT mice, body
weight before the start of the dietary intervention (week 12)
was negatively correlated with lifespan. However, as early as
12 weeks after begin of the dietary intervention (week 24),
body weight of both WT and TG mice showed a signiﬁcant neg-
ative correlation with lifespan, which was even stronger in both
genotypes combined. This was mainly linked to body fat con-
tent, which showed a very similar negative correlation to life-
span. Interestingly, maximum body fat levels were less good
predictors of lifespan, suggesting that early increases in body fat
are more deleterious than the maximum fatness reached in life.
Also, the time at which maximum body fat was reached showed
the strongest correlation (r = 0.605, P < 0.0001, WT and TG
combined) with lifespan of all measured parameters. However,
this time variable is not independent from lifespan, which is also
a time variable (mice that live longer have more time to accumu-
late body fat). Therefore, we calculated the rate of body fat gain
(as described above), which proved to be a strong predictor of
life expectancy explaining about 23% of lifespan variation in WT
mice (Table 4). This is strongly supported by data in TG mice,
which showed a similar correlation with the rate of body fat
gain. There was no signiﬁcant difference in the respective
regression curves between WT and TG although TG mice are sig-
niﬁcantly smaller (Katterle et al., 2008) and lighter than WT. In
WT and TG combined, the rate of fat gain explained over 30%
of the variation in life expectancy (r
2 = 0.31, P < 0.0001).
Besides energy intake, energy expenditure can also contribute
to body weight gain. TEE per animal (measured in week 31)
showed a negative correlation with lifespan. However, as
pointed out before, total TEE is to over 80% determined by body
weight, which by itself is negatively correlated to lifespan.
Therefore, we also calculated weight-speciﬁc daily TEE, which
showed a very strong negative correlation with both body
weight and body fat gain from week 12 to 40 (R = )0.794 and
)0.715, respectively, P < 0.0001, WT and TG combined). Fur-
thermore, weight-speciﬁc TEE showed a less strong, but still
highly signiﬁcant correlation with lifespan (R = 0.416,
P < 0.0001) in WT and TG combined. Physical activity levels on
the other hand did not show any correlation with lifespan in
either WT or TG mice (Table 4).
Not only early changes in energy metabolism, but also in glu-
cose homeostasis are apparently predictive of aging and life-
span. Blood glucose at week 24 but not at later time points
showed a signiﬁcant negative correlation with lifespan
(R = )0.329, P < 0.001; WT and TG together). On the other
hand, insulin levels from 24 weeks of age on showed a signiﬁ-
cant negative correlation with lifespan in WT and TG combined,
indicating that increased insulin levels throughout life are corre-
lated with a decreased lifespan. In this context, it is important to
note that body fat content in week 24 was very strongly corre-
lated with insulin levels at the same time point (R = 0.835,
P < 0.0001, TG and WT combined). Body fat content thus
explains 70% of the variation in insulin levels, but only 40% of
the variation in blood glucose (R = 0.635, P < 0.0001, TG and
(A) (B)
Fig. 6 Glucose tolerance test performed at 60 weeks of age in wild-type (WT) and transgenic (TG) (HSA-UCP1) mice fed three different semisynthetic
macronutrient diets ad libitum from 12 weeks of age. Blood glucose levels in male (A) and female (B) mice until 240 min after glucose injection (n = 7–13).
Glucose (2 mg g
)1) was applied i.p. to 3-h fasted mice (n = 7–13). The inserts show corresponding insulin levels before, 15, and 30 min after glucose application.
Macronutrients, energy metabolism, and longevity, S. Keipert et al.
ª 2010 The Authors
Aging Cell ª 2010 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
129WT combined). HOMA-IR as a surrogate for insulin resistance
also showed a signiﬁcant negative correlation with lifespan from
24 weeks on, suggesting that early development of insulin resis-
tance is predictive of a reduced lifespan (Table 4).
Discussion
It is well recognized that aging and longevity are complex
characteristics, which are determined by an interplay of genes
and environment, with nutrition certainly being one of the
most important environmental factors. Recent advances in
mouse genetics and the generation of a vast number of genet-
ically modiﬁed mouse strains have let to the identiﬁcation of a
number of genes and pathways linked to aging and lifespan.
Especially mutant mice with increased longevity are currently
investigated to elucidate mechanisms of aging and longevity
(Ladiges et al., 2009; Chen et al., 2010). Genetic manipula-
tions in mice leading to alterations in energy metabolism
which in turn affect lifespan or aging are suggestive of an
important role of metabolic status in the regulation of aging
and lifespan (Gates et al., 2007; Wenz et al., 2009; Tocchetti
et al., 2010). On the other hand, only little is known about the
effects of diet composition on lifespan in mice and even less
about the interaction of dietary macronutrient composition
and genetic factors with regard to aging and longevity. Here,
we show (i) that dietary macronutrient ratios strongly affect
obesity development, glucose homeostasis, and longevity in
mice, (ii) that skeletal muscle mitochondrial uncoupling allevi-
ates the detrimental effects of high-fat diets on metabolic sta-
tus and longevity, and (iii) that an early, rapid body fat
accretion leading to increased insulin resistance is predictive
for a decreased lifespan.
Macronutrient ratios strongly affect longevity, body
composition, and insulin sensitivity
The diet composition was chosen to be able to dissect the spe-
ciﬁc roles of carbohydrates, protein, and fat, respectively.
Although we did not include a chow fed control group, we
assume that feeding of our semisynthetic diets did not lead to a
reduced lifespan. The median lifespan of WT mice on the control
(HCLF) diet was 798 and 825 days for males and females,
respectively, and thus well within the range reported for
C57BL⁄6J mice (866 days males, 782 days females) and mark-
edly higher than that reported for CBA⁄J mice (679 days males,
644 days females) fed a standard low-fat chow diet and kept in
a speciﬁc pathogen-free environment (Yuan et al., 2009). Thus,
we are conﬁdent that lifelong feeding of semisynthetic diets
supplemented with essential nutrients has no adverse effects on
aging and is suitable for use in longevity studies. We analyzed
the lifespan in mice of a mixed C57BL⁄6-CBA background that
were inbred for several years. It has been suggested that lifespan
studies should be conducted on mice with a uniform genetic
background and that a uniform hybrid strain background (as
used here) might help minimize idiosyncratic problems associ-
ated with some inbred strains (Ladiges et al., 2009).
Concerning dietary effects on WT mice, the survival data
clearly show that a diet high in fat and carbohydrates (HCHF) is
more deleterious to life expectancy than a diet with the same fat
content but decreased carbohydrate and thus increased protein
content (LCHF). This argues against the hypothesis that a high
protein to nonprotein energy ratio reduces lifespan but under-
scores the idea that the dietary macronutrient balance rather
than the absolute macronutrient intake affect lifespan predomi-
nantly (Simpson & Raubenheimer, 2009). The reduced
Table 4 Spearman correlation coefﬁcients of selected phenotypic markers with life expectancy of wild-type (WT) and transgenic HSA-UCP1 (TG) mice fed three
different semisynthetic macronutrient diets. Male, female and diet groups were combined
Correlation coefﬁcient
WT (n)T G ( n) WT+TG (n)
Body weight week 12 (g) ns (115) )0.419*** (125) )0.423*** (240)
Body weight week 24 (g) )0.397*** (114) )0.451*** (125) )0.506*** (239)
Body fat week 24 (g) )0.338*** (114) )0.386***(125) )0.471*** (239)
Maximum body fat (g) )0.197* (115) )0.238* (125) )0.373*** (240)
Time of maximum body fat (week) 0.427*** (115) 0.658*** (125) 0.605*** (240)
Rate of fat gain (g per week) )0.475*** (115) )0.501*** (125) )0.561*** (240)
TEE (kJ per day) )0.406** (62)** )0.391** (61) )0.520*** (123)
Weight-speciﬁc TEE (kJ ⁄ d*g BW) ns (62) 0.232* (61) 0.416*** (123)
Physical activity (wk31) ns (62) ns (56) ns (118)
Glucose week 12 (mg dL
)1) ns (48) ns (61) ns (109)
Glucose week 24 (mg dL
)1) )0.292* (54) ns (66) )0.329*** (120)
Insulin week 24 (lgL
)1) ns (52) ns (66) )0.282*** (118)
HOMA-IR week 24 )0.316* (52) ns (66) )0.315***(118)
Glucose week 60 (mg dL
)1) ns (52) ns (62) ns (114)
Insulin week 60 (lgL
)1) ns (52) ns (61) )0.310** (114)
HOMA-IR week 60 ns (52) )0.270* (59) )0.313***(111)
Rate of fat gain corresponds to the weekly increase in body fat from week 12 to the time of maximum body weight. Animal numbers are in brackets.
TEE, total energy expenditure; HOMA-IR, Homeostasis Model Assessment for insulin resistance.
*P < 0.05, **P < 0.01, ***P < 0.001; ns: nonsigniﬁcant.
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130detrimental effect of the LCHF diet on longevity is very strongly
linked to the differential effect of the two high-fat diets on adi-
posity development. Although the LCHF diet contained over 40
energy% of fat, it did not lead to higher maximum adiposity lev-
els than the control HCLF diet with only 17 energy% of fat. The
lower body fat gain on the LCHF diet compared to the HCHF diet
is probably because of a decreased hyperphagia when protein
content of a high-fat diet is increased, which could be related to
the known satiating effects of protein (Westerterp-Plantenga
et al., 2009). Although we did not measure food intake, our
previous data using the same diet composition showed that dif-
ferences in body weight gain in WT and TG mice on the different
diets were predominantly dependent on energy intake. TG mice
were found to show a lower energy intake than WT per animal
but an increased weight-speciﬁc energy intake compared to WT
(Katterle et al., 2008).
To our knowledge, our study is the ﬁrst showing the individual
developmentofbodycomposition throughoutlifeanditsdepen-
dence on diet composition in mice. Body composition measure-
ments of BL6 mice on a standard chow diet until 2 years of age
showed very similar development of body composition as our
mice on the control (HCLF) diet, i.e. a steady increase in body fat
until over 1 year of age and a decrease in fat mass starting
between 80 and 90 weeks of age (Berryman et al., 2010). Fur-
thermore, similar to our study, Berryman et al. (2010) found
LBMtoberatherstablefromabout20 weeksofageon.Interest-
ingly,althoughmiceonthecontroldiet(HCLF)showedagradual
decline in body weight from about 40 and 80 weeks on in males
and females, respectively, this was exclusively owing to a loss of
body fat and not of lean mass. Lean mass was not inﬂuenced by
diet except in male WT mice on the HCHF diet, which had about
5 g more lean weight after about 60 weeks of age compared to
the other groups, the reason for thisnot beingclear yet.
Obesity is associated with disturbances in glucose homeosta-
sis, which can result in the development of type 2 diabetes.
Therefore, we assessed glucose homeostasis by regular mea-
surements of blood glucose and insulin, calculation of HOMA-
IR, and by performing a glucose tolerance test at 60 weeks of
age. The results show clearly that the hybrid mouse strain used
here is not very susceptible to the development of diabetes
because individual blood glucose levels in 2- to 3-h fasted mice
never exceeded 200 mg dL
)1 until 60 weeks of age and were
thus well below the overt diabetes threshold of glucose, which
is considered 20 mM (360 mg dL
)1) for mice (Plum et al., 2000).
Nevertheless, insulin sensitivity decreased with age as evident
from HOMA-IR. Insulin resistance was consistently higher in
males than in females, which is in accordance with the human
situation with women considered to be more insulin sensitive
than men (Geer & Shen, 2009). Remarkably, there were no diet
effects on glucose tolerance in week 60. The ability of HCHF fed
mice to maintain normal glucose levels during GTT was obvi-
ously attributed to increased basal insulin levels and a fast
increase in insulin secretion upon glucose stimulation which
compensated for the increased insulin resistance of the HCHF
mice. This shows that a habitual high carbohydrate intake led to
an adaptive increase in insulin production capacity. Using similar
macronutrient diets, we have shown previously that increasing
the protein:carbohydrate ratio in a high-fat diet delayed the
development of adiposity and improved glucose homeostasis in
mice after 10 weeks of ad libitum feeding) (Klaus, 2005). It is
now widely accepted that the insulin⁄IGF-1 pathway plays a
prominent role in aging and life expectancy (Bartke, 2008; Nara-
simhan et al., 2009; Blagosklonny et al., 2010) and many
genetic models of increased longevity have mutations in genes
of this pathway such as, Igf-1 receptor +⁄) mice, fat-speciﬁc
insulin receptor knockout mice, and Irs-1 knockout mice
(reviewed in Chen et al., 2010; Ladiges et al., 2009).
Skeletal muscle mitochondrial uncoupling alleviates
detrimental effects of high-fat diets
Altogether our data show that increased muscle mitochondrial
uncoupling can alleviate most of the deleterious effects of high-
fat diets on aging and survival. Using a different transgenic
mouse line with ectopic expression of UCP1 in skeletal muscle
(driven by a different promoter than used in our model), Gates
and coworkers (2007) showed that these mice had an increased
median lifespan of about 10% when kept on a standard chow
diet although they did not ﬁnd a signiﬁcant increase in maxi-
mum lifespan. Lifespan on different diets was not investigated.
Our results suggest that the positive metabolic effects of ectopic
UCP1 expression in skeletal muscle are highly reproducible.
Pooling of mice of all diet groups and both genders revealed a
shift toward later mortality in HSA-UCP1 mice. Even more
remarkably, TG mice proved to be mostly resistant to the delete-
rious effect of high-fat diets on longevity HCHF feeding
decreased median lifespan of WT by 33% but that of TG mice
by only 7% compared to the control diet. Similar results were
observed with regard to glucose homeostasis. Insulin sensitivity
was much higher in TG than in WT mice as evident from insulin
levels and HOMA-IR. A hallmark of mice with ectopic expression
of UCP1 in skeletal muscle is indeed the increased insulin sensi-
tivity accompanied by decreased insulin levels, especially under
high-fat diet conditions that was observed in our HSA-UCP1
mice, as well as in the transgenic mouse line used by Gates and
coworkers (Li et al., 2000; Klaus et al., 2005; Katterle et al.,
2008; Neschen et al., 2008), and which was still evident on a
genetically obese background (Bernal-Mizrachi et al., 2002).
Using insulin tolerance test and hyper insulinemic-euglycemic
clamps, we have previously shown increased an insulin sensitiv-
ity of HSA-UCP1 mice on chow and high-fat diets compared to
WT littermates (Katterle et al., 2008; Neschen et al., 2008).
Here, we show additionally that these positive effects seem to
persist throughout aging and are therefore most probably linked
to the increased survival of HSA-UCP1 mice on high-fat diets.
It is interesting to note that TG mice are of overall smaller body
size than wild-type (Klaus et al., 2005; Katterle et al., 2008).
Small body size is a striking characteristic of most long-lived
mouse mutants such as the Ames Dwarf, Snell Dwarf and Little
mouse (reviewed in Bartke, 2005). However, it is assumed that
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131small body size per se is not causative for delayed aging, but
rather a phenotypic marker of developmental or metabolic char-
acteristics that predispose to increased life expectancy (Bartke,
2005).Ithasrecentlybeenshownthatearlylifegrowthhormone
(GH) treatment of GH-deﬁcient long-lived Ames dwarf mice
reduced their lifespan to that of control mice although it failed to
completely restore their body weight to control levels (Panici
et al.,2010).
The reason for the increased longevity of mice with skeletal
muscle uncoupling is not yet clear. It could be attributed to the
increased mitochondrial uncoupling itself, which has been sug-
gested to increase longevity by preventing the formation of ROS
and was termed the ‘uncoupling to survive’ hypothesis (Brand,
2000). It was reported that individual outbred mice with high
metabolic rates showed higher mitochondrial uncoupling and
survived longest (Speakman et al., 2004), thus linking high rates
ofenergyexpendituretoincreasedsurvival.Thisseemstobecon-
ﬁrmed by our data showing increased weight-speciﬁc energy
expenditure in TG mice irrespective of the diet. However, it
should be noted that normalization of energy expenditure to
body weight might not be ideal when comparing mice with
largely different LBM and fat mass (FM). Regression-based
approaches that account for variation in both FM and LBM might
be better for normalization of energy expenditure in mice
(Kaiyalaet al.,2010).
High rate of fat gain and early development of
insulin resistance as predictive markers for
decreased lifespan
When correlating markers of energy and glucose homeostasis
with lifespan, inclusion of TG mice provides the opportunity to
broaden the range of phenotypic variation and to conﬁrm data
obtained in WT in a mouse line with known alterations in energy
and glucose homeostasis. In TG mice, body weight at the start of
the feeding trial was negatively correlated with lifespan, which
suggests that the ability of TG to resist deleterious diet effects is
strongly linked to the early manifestation and penetration of the
transgenicphenotypewithregardtobodymasseffects.
In WT as well as in TG mice, body fat at 24 weeks of age was
a better predictor of lifespan than maximum body fat, which
was still the case when both genotypes were combined. This
suggests that the maximum adiposity reached throughout life is
not the most detrimental factor, but rather an early, rapid accre-
tion of body fat after the dietary switch. This is supported by the
fact that the rate of body fat gain was one of the strongest pre-
dictors, explaining over 30% of the variation in life expectancy.
Correlations per se are not necessarily indicative of a direct
causal relationship. However, the observed covariations of the
described biomarkers with individual lifespan suggest very
strongly that deleterious effects of a high-fat diet on aging
and longevity are because of an early rapid body fat accumula-
tion which in turn leads to increased insulin resistance. This is
manifested by early increases in blood glucose, which are com-
pensated later on by a continuously increased insulin secretion.
These conclusions are strongly supported by the results
obtained in the TG mice which showed overall increased insu-
lin sensitivity, and in particular a delayed development of insu-
lin resistance on the high-fat diet resulting in increased
longevity on these diets.
As mentioned before, the insulin⁄IGF1 pathway is thought to
play a prominent role in aging and life expectancy. However,
studies on different long-lived mouse models suggest that the
role of insulin in longevity is very complex. Several mutants such
as the Ames and Snell dwarf mice (Dominici et al., 2002; Flurkey
et al., 2002) or transgenic mouse models like the S6K knockout
mouse (Selman et al., 2009) show extended lifespan as well as
increased insulin sensitivity. The GH and IGF1 system have com-
plex feedback mechanisms that, in general, promote insulin
resistance (Dominici et al., 2005). Masternak et al. (2010) could
show that in normal, Ames dwarf, and GH receptor knockout
mice, changes in whole body insulin sensitivity were associated
with lifespan alterations. They conclude that enhanced insulin
sensitivity is a potential marker of increased life expectancy. On
the other hand, several reports have shown an increased life-
span in relatively insulin resistant mouse lines such as female IRS-
1 null mice (Selman et al., 2008) and brain-speciﬁc IRS-2 null
mice (Taguchi et al., 2007). In our study, early development of
insulin resistance (HOMA-IR week 24) explained only about
10% of the variability in life expectancy of WT and TG together,
suggesting that other, possibly independent factors must be
involved in determination of lifespan.
Sofar, the molecular mechanisms leading to the increased sur-
vival of HSA-UCP1 mice on the high-fat diets are still not known.
It could be linked to a down regulation of ribosomal S6 protein
kinase signaling, which was reported to regulate mammalian
lifespan supposedly by increasing activity of AMP activated pro-
tein kinase (AMPK) (Selman et al., 2009), a master regulator of
cellular energy homeostasis (Hardie, 2008). Skeletal muscle
mitochondrial uncoupling activates AMPK (Gates et al., 2007;
Neschen et al., 2008), and, in turn, AMPK has been shown to
regulate energy metabolism by modulating the activity of the
histone⁄protein deacetylase SIRT1 (Canto et al., 2009), a mole-
cule supposed to be involved in gene expression changes that
mediate the increase in longevity induced by caloric restriction
(Ruderman et al., 2010). One downstream target of AMPK is the
mammalian target of rapamycin (mTOR), an important regulator
of growth control and metabolism, which is inhibited by AMPK
(Kimball, 2006; Shaw, 2009). mTOR has been found to be over-
expressed in obesity-linked insulin resistance in mice (Khamzina
et al., 2005; Tremblay et al., 2007) and to be upregulated by
chronic lipid availability in rats, which could be reversed by exer-
cise training leading to AMPK activation (Rivas et al., 2009).
Chronic nutrient excess thus seems to activate mTOR-S6 signal-
ing, which could be counteracted by increased AMPK activity in
TG mice. We have previously shown increased skeletal muscle
AMPK activation in HSA-UCP1 mice fed a standard chow diet
(Neschen et al., 2008). It remains to be investigated if this upreg-
ulation of AMPK activity is still evident after long-term feeding of
the high-fat diets used here andif itaffects mTOR signaling.
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132Interestingly, it has been shown in Caenorhabditis elegans
that glucose restriction increased lifespan by inducing mitochon-
drial respiration and increasing oxidative stress (Schulz et al.,
2007), leading to the development of the concept of mitohor-
mesis (Ristow & Zarse, 2010). This concept suggests that
increased formation of reactive oxygen species causes an adap-
tive response by increasing oxidative defense, and thereby ulti-
mately leading to reduced oxidative stress. This provides a
common mechanistic denominator for the positive effects of dif-
ferent metabolic interventions on lifespan such as calorie restric-
tion, glucose restriction, and physical activity (Ristow & Zarse,
2010). We have shown a decreased ROS production in isolated
muscle mitochondria of HSA-UCP1 mice in vitro (Keipert et al.,
2010), and preliminary data are indicative of decreased oxidative
stress in muscle of TG mice even on high-fat feeding (S. Keipert,
A. Voigt, unpublished data), suggesting that decreased oxida-
tive stress could also be a mechanism by which skeletal muscle
mitochondrial uncoupling affects aging and longevity.
It remains to be established whether one or several of the
described pathways are involved in the regulation of lifespan in
our model of combining dietary and metabolic intervention.
Conclusions
Altogether our study suggests that harmful effects of high-fat
diets on lifespan are predominantly linked to early and rapid
increases in body fat content, which then lead to early develop-
ment of insulin resistance. A reduction in dietary carbohydrate
in favor of protein ameliorates the damaging effects of high die-
tary fat exposure by reducing body fat accretion and thus blunt-
ing early increases in glucose levels, thereby delaying the
development of insulin resistance and hyper-insulinemia. Even
without the development of manifest type 2 diabetes, chroni-
cally elevated insulin levels and insulin resistance are linked to a
decreased lifespan and represent a better predictive marker for
reduced longevity than glucose levels alone. Furthermore, a
genetic manipulation, which leads to increased weight-speciﬁc
energy expenditure, reduced body weight, and increased insulin
sensitivity, was able to almost completely alleviate the detrimen-
tal effects of high-fat diets apparently not by preventing but
rather by decelerating the rate of body fat accretion and thus
retaining insulin sensitivity and reduced insulin levels over a
longer time period. This strong inﬂuence of energy metabolism
on longevity – especially under unfavorable dietary conditions –
suggests that behavioral or pharmacological interventions that
target energy metabolism could be able to counteract detrimen-
tal long-term dietary effects on aging and longevity.
Experimental procedures
Animal maintenance and longevity study
HSA-mUCP1 animals were generated as previously described
(Klaus et al., 2005). Experiments were performed with male and
female heterozygous HSA-mUCP1 and wild-type (WT) controls
maintained on a mixed C57BL⁄6 – CBA background. Mice were
housed in groups of same sex littermates with ad libitum access
to food and water at a temperature of 22 C. Animal mainte-
nance and experiments were approved by the animal welfare
committee of the Ministry of Agriculture and Environment (State
of Brandenburg, Germany).
Diets
At 12 weeks of age, mice were switched from standard chow
diet to one of three semisynthetic diets with different macronu-
trient composition (Table 5). As a control diet a low-fat high-car-
bohydrate diet was used (HCLF). The two high-fat diets (HCHF,
LCHF) had the same fat content but differed in their protein:car-
bohydrate ratio. The high-carbohydrate⁄high-fat diet (HCHF)
was matched in carbohydrate content, and the low-carbohy-
drate⁄high-fat diet (LCHF) was matched in protein content to
the control diet to analyze macronutrient effects.
Analyses of mouse survival
Survival was assessed from 17 to 23 female mice per group and
18–26 male mice per group. All animals are dead by the time of
this report. Between 3 and 9 months of age, we measured a ser-
ies of parameters relating to individual aspects of energy balance
and glucose homeostasis as described above. Mice were moni-
tored daily until they died or were euthanized when they were ill
and it was judged that they would not survive for several more
days. This time point was entered in the survival statistics.
Following criteria for euthanasia were applied: severe weight
loss over a period of several days, body fat levels below inability
to eat or drink, extreme lethargy (i.e. reluctance to move upon
gentle prodding), profound bleeding from open sores or tumors.
A higher percentage of mice had to be euthanized on the two
high-fat diets apparently because of the increased incidences of
Table 5 Composition of the different semisynthetic diets*
Control
high-
carbohydrate⁄
low-fat
High-
carbohydrate⁄
high-fat
Low-
carbohydrate
⁄high-fat
Casein (g kg
)1) 410 180 500
Wheat starch (g kg
)1) 370 430 80
Saccharose (g kg
)1) 5 05 05 0
Palm kernel fat (g kg
)1) 50 180 180
Thistle oil (g kg
)1) 1 01 01 0
Linseed Oil (g kg
)1)1 01 01 0
Cellulose (g kg
)1) 30 70 100
Mineral mixture (g kg
)1) 5 05 05 0
Vitamin Mixture (g kg
)1) 2 02 02 0
Metabolizable energy (kJ g
)1) 15.5 17.7 17.5
Protein (energy %) 41.7 16.0 45.0
CHO (energy %) 41.1 41.0 11.5
Fat (energy %) 17.2 43.0 43.6
*Diet components as described (Daenzer et al., 2002).
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133scratching-related sores and rapid weight loss. However, there
was no apparent genotype effect on this percentage. In order
not to stress the animals too much, they were divided into two
groups subjected to different measurements as described
below. We found no differences in survival between the two
treatment groups, suggesting that the measurements had no
inﬂuence on lifespan.
Body composition
Body weight and composition were determined monthly using
quantitative magnetic resonance (QMR) (Bruker‘s Minispec
MQ10, Housten, TX, USA), a noninvasive method to measure
body composition (Tinsley et al., 2004).
Glucose and energy metabolism
The genotypes on the different diets were divided into two
groups of 7–12 animals per gender. In the ﬁrst group, blood glu-
cose was determined (3 h after food withdrawal) every
12 weeks in whole blood from the tail using a common glucose
sensor (Bayer, Germany) and plasma insulin by an ultra-sensitive
ELISA assay (DRG Instruments GmbH, Germany). Plasma insulin
levels of several transgenic mice were at or below the detection
threshold of 0.175 lgL
)1 at 12 weeks of age. In these cases,
0.175 lgL
)1 was entered for calculation of mean levels for ﬁg-
ure presentation (Fig. 5C,D) but values were not included in sta-
tistical calculations. After 48 weeks of dietary intervention
(week 60), an intra-peritoneal (i.p.) glucose tolerance test (GTT)
was performed. Glucose (2 mg g
)1 body weight, 20% solution)
was applied i.p. three hours after food withdrawal. Insulin levels
were measured before, 15, and 30 min after glucose applica-
tion. Homeostasis Model Assessment for insulin resistance
(HOMA-IR) was calculated as described by Lansang et al. (2001)
using the following function: fasting plasma glucose
[mM] · fasting plasma insulin [pM]⁄22.5.
In the second group, energy expenditure of single mice was
measured by indirect calorimetry over 24 h using an open respi-
rometric system after 19 weeks of dietary intervention (week 31
of age), as described before (Katterle et al., 2008). Mice were
kept in normal housing cages and had free access to food and
water during the measurement. After indirect calorimetry mea-
surements, spontaneous physical activity was assessed in the
same cages over a period of 4 days using an infrared method
(TSE Systems GmbH, Germany).
Statistical analyses
Statistical analyses were performed using Stat Graph Prism 5.0
(La Jolla, CA, USA). Kaplan–Meier survival curves were con-
structed using known birth and death dates with differences
between groups evaluated using the log-rank (Mantel-Cox)
test. Data were tested for normal distribution and one-way or
two-way ANOVA was used to evaluate differences between
groups with appropriate post hoc tests for normally distributed
data. Not normally distributed data were analyzed using a
nonparametric test (Mann–Whitney test). Statistical signiﬁ-
cance was assumed at P < 0.05. Correlations (Spearman) were
calculated between phenotypic markers and lifespan. Two-
tailed P values were computed. Data are reported as mean ± -
SEM unless otherwise indicated.
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